Characteristics of Patients With Necrotizing Soft Tissue Infections
Sponsor
Aarhus University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04801615
Collaborator
(none)
30
1
57
0.5
Study Details
Study Description
Brief Summary
To study the demographic characteristic of patients with necrotizing soft tissue infections.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
At Aarhus University Hospital, Denmark, all patients with necrotizing soft tissue infections will be registered in a database in order to be able to describe their symptoms, demographic variables and thier treatment (surgery, time to surgery, antibiotics, intensive care unit, laboratory data etc).
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Demographic Characteristics, Symptoms, Treatment and Mortality of Patients With Necrotizing Soft Tissue Infections
Actual Study Start Date
:
Sep 1, 2020
Anticipated Primary Completion Date
:
Jan 1, 2025
Anticipated Study Completion Date
:
Jun 1, 2025
Outcome Measures
Primary Outcome Measures
- Percentage of patients that dies within 1 year following admission date [12 months following admission date]
The risk of death within 1 year
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Patients diagnosed with necrotizing soft tissue infections and treated at Aarhus Universital Hospital
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Aarhus University Hospital | Aarhus N | Denmark | 8200 |
Sponsors and Collaborators
- Aarhus University Hospital
Investigators
- Principal Investigator: per gundtoft, Aarhus University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Per Gundtoft,
Principal Investigator, Consultant, PhD,
Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT04801615
Other Study ID Numbers:
- ICD_20201212
First Posted:
Mar 17, 2021
Last Update Posted:
Oct 7, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: